Whitehawk Therapeutics (WHWK) Consolidated Net Income (2010 - 2026)
Whitehawk Therapeutics (WHWK) reported Consolidated Net Income of -$22.2 million for Q1 2026, down 130.4% year-over-year from $73.0 million in Q1 2025, and down 125.57% on a QoQ basis from $86.8 million in Q4 2025.
Whitehawk Therapeutics (WHWK) has 17 years of Consolidated Net Income data on file, last reported at -$22.2 million in Q1 2026.
- Quarterly Consolidated Net Income fell 130.4% year-over-year to -$22.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.9 million (down 121.22% YoY) and the FY2025 annual result came in at -$20.6 million, up 67.66% from the prior year.
- Consolidated Net Income fell to -$22.2 million in Q1 2026 per WHWK's latest filing, from $86.8 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at $86.8 million in Q4 2025 and bottomed at -$52.8 million in Q2 2025.
- The 5-year median for Consolidated Net Income is -$16.3 million (2023), against an average of -$7.2 million.
- The widest annual swing landed in 2022, when Consolidated Net Income plunged 1089.39%; it then jumped 575.01% in 2025.
- Tracing WHWK's Consolidated Net Income over 5 years: stood at -$13.9 million in 2022, then fell by 16.93% to -$16.3 million in 2023, then declined by 12.32% to -$18.3 million in 2024, then jumped by 575.01% to $86.8 million in 2025, then tumbled by 125.57% to -$22.2 million in 2026.
- Per Business Quant, the three latest WHWK Consolidated Net Income figures stand at -$22.2 million (Q1 2026), $86.8 million (Q4 2025), and -$17.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -8.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.40 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | -22.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.19 Mn |
| Dec 31, 2025 | 86.80 Mn |
| Sep 30, 2025 | -17.70 Mn |
| Jun 30, 2025 | -52.77 Mn |
| Mar 31, 2025 | 73.02 Mn |
| Dec 31, 2024 | -18.27 Mn |
| Sep 30, 2024 | -12.55 Mn |
| Jun 30, 2024 | -14.58 Mn |
| Mar 31, 2024 | -18.29 Mn |
| Dec 31, 2023 | -16.27 Mn |
| Sep 30, 2023 | -16.30 Mn |
| Jun 30, 2023 | -17.97 Mn |
| Mar 31, 2023 | -15.22 Mn |
| Dec 31, 2022 | -13.91 Mn |
| Sep 30, 2022 | -14.47 Mn |
| Jun 30, 2022 | -18.27 Mn |
| Mar 31, 2022 | -13.86 Mn |
| Dec 31, 2021 | -15.99 Mn |
| Sep 30, 2021 | -87.09 Mn |
| Jun 30, 2021 | -1.54 Mn |
| Mar 31, 2021 | -5.48 Mn |
| Dec 31, 2020 | 8.02 Mn |
| Sep 30, 2020 | -2.89 Mn |
| Jun 30, 2020 | 9.28 Mn |
| Mar 31, 2020 | -4.00 Mn |
| Dec 31, 2019 | -4.49 Mn |
| Sep 30, 2019 | -4.73 Mn |
| Jun 30, 2019 | -5.69 Mn |
| Mar 31, 2019 | -8.51 Mn |
| Dec 31, 2018 | -8.52 Mn |
| Sep 30, 2018 | 11.53 Mn |
| Jun 30, 2018 | -5.99 Mn |
| Mar 31, 2018 | -7.43 Mn |
| Dec 31, 2017 | -6.24 Mn |
| Sep 30, 2017 | -4.70 Mn |
| Jun 30, 2017 | -5.53 Mn |
| Mar 31, 2017 | -5.03 Mn |
| Dec 31, 2016 | -3.54 Mn |
| Sep 30, 2016 | -4.91 Mn |
| Jun 30, 2016 | -4.47 Mn |
| Mar 31, 2016 | -4.21 Mn |
| Dec 31, 2015 | -11,832.00 |
| Sep 30, 2015 | -6,521.00 |
| Jun 30, 2015 | -7,272.00 |
| Mar 31, 2015 | -5,815.00 |
| Dec 31, 2014 | -11,653.00 |
| Sep 30, 2014 | -6,428.00 |
| Jun 30, 2014 | -6,952.00 |
| Mar 31, 2014 | -5,766.00 |
| Dec 31, 2013 | -9,750.00 |
| Sep 30, 2013 | -6,139.00 |
| Jun 30, 2013 | -6,749.00 |
| Mar 31, 2013 | -6,063.00 |
| Dec 31, 2012 | -9,662.00 |
| Sep 30, 2012 | -6,038.00 |
| Jun 30, 2012 | -6,303.00 |
| Mar 31, 2012 | -5,362.00 |
| Dec 31, 2011 | -8,934.00 |
| Sep 30, 2011 | -6,337.00 |
| Jun 30, 2011 | -6,760.00 |
| Mar 31, 2011 | -5,154.00 |
| Dec 31, 2010 | -7,746.00 |
| Sep 30, 2010 | -4,767.00 |